Arizona is home to one of the fastest growing biotech sectors in the
country with over 1300 life science companies. Recent industry successes
include the top performing IPO of 2013 (Insys Therapeutics, Inc.) and
the 2014 acquisition of Ulthera for $600M. Arizona researchers have
contributed to the development of the drug that saved the lives of two
health workers infected with the Ebola virus, designed and built
revolutionary cardiac medical devices, pioneered new diagnostics and
cancer therapies, and a wealth of other life science innovations that
are benefiting patients here at home and around the world.
Arizona Bioscience Week, September 15, 2014 to September 19,
2014, celebrates these successes while providing the community with the
opportunity to learn more about the vital work being done to improve
health and stimulate the state's economy.
For those working in the industry, these life science innovations come
as no surprise, but many members of the community do not have the
opportunity to connect with Arizona's life science innovators to see
what is here and what is still to come. For this reason, the Arizona
Bioindustry Association (AZBio) is holding a free Biotech Showcase
on September 17th from 3:00 PM to 6:00 PM in the North
Ballroom of the Phoenix Convention Center featuring displays from Life
Science Companies and Arizona Universities. In addition, students from
Arizona high schools, community colleges and universities will showcase
their work in a Student Discovery Zone sponsored by Northern
Arizona University and award-winning life science entrepreneurs will
share their experience with the community on the "Best of the Best"
stage sponsored by life science accelerator BioAccel.
"This is a great opportunity for Arizonans to come and see what is
happening in our state," shared Joan Koerber-Walker, president and CEO
of AZBio. "Innovations in healthcare impact all of us personally at one
time or another and the economic impact to our state is significant
based on economic impact analysis by Battelle Technology Partnership
Practice, which estimated that Arizona's bioscience industry generates
total annual revenue of $14 billion. When you include our hospitals,
that figure exceeds $36 billion."
The Arizona Biotech Showcase is free and open to the public from 3:00PM
to 5:45 PM on Wednesday, September 17th at the Phoenix
Convention Center. More information is available at AZBio.org/ABW.
Each year AZBio honors bioindustry leaders from across Arizona that
illustrate the depth, breadth, and expertise of its bioscience industry.
Over 400 leaders will gather the evening of September 17th to
honor the researchers, leaders, and companies that are driving Arizona
bioindustry growth at the 2014 AZBio Awards from 6:00 PM to 9:00 PM. The
celebration will include a leadership conversation on the importance of
life science innovation with Arizona Gubernatorial Candidates Fred DuVal
and Doug Ducey along with ceremonies honoring Arizona's life science
leaders and innovators:
Investing in the future
The West was won by innovators, investors, and prospectors who
understood the value of discovery and accepted the challenge of
investing in new frontiers. On September 18th, a new
generation of biotech and healthcare pioneers will take the stage at White
Hat Investors 2014, the first annual biotech and healthcare
investor conference that showcases the best of the Rocky Mountain &
Today's life science pioneers build success through multi-level
collaborations across a spectrum from discovery to development to
delivery. Partnerships range from academic institutions to private
research institutes, entrepreneurs, global corporations, and investors
at all levels and stages that recognize that what you invest in matters
and that there is something special about fueling the growth of
companies that improve the human condition. At White Hat Investors
2014 companies that are tackling some of the world's greatest
challenges including HIV/AIDS, Neurological Disorders, Heart Disease and
Cancer along with others that are developing solutions to diagnose
disease, monitor the effectiveness of treatment and deliver new
therapies will present investment opportunities to the region's accredited
investors. Their work takes different forms as apps, tests, drugs,
biologics, and medical devices, but the ultimate end goal is the same,
to make life better for people here at home and around the world.
"Developing life science companies takes a bit longer than building an
app to make restaurant reservations or a website to share photos with
your friends. Nor do life science innovations pop up like a building
that you can drive by or walk into," shared AZBio president & CEO Joan
Koerber-Walker. "Life science innovators must navigate through the
clinical trials and regulatory process, negotiate reimbursements across
a changing healthcare landscape and work tirelessly to both build their
businesses and attract the capital they need to grow. At the end of that
journey the rewards can be significant financially, but even more
rewarding is the knowledge that you were part of a cure, helped
alleviate pain, or made life better for others in a myriad of ways."
White Hat Investors 2014 provides accredited investors from
across the region with the opportunity to interface with life science
innovators as wells as angel investors, strategic investors and venture
capitalists with decades of experience. The presenting companies were
selected from across the Rocky Mountain Southwest Region and include:
For more information on White Hat Investors 2014 including times,
dates, location and registration information, visit www.WhiteHatInvestors.com.
investors interested in learning more about this exciting industry
sector receive complimentary registration to both the AZBio Awards
Dinner and White Hat.
Images available upon request.
[ Back To NFVZone's Homepage ]